Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Yung Shin Pharmaceutical Industry Co., Ltd.
EIR
•Yung Shin Pharmaceutical Industry Co., Ltd.•September 12, 2019

Yung Shin Pharmaceutical Industry Co., Ltd. – FDA EIR, Sep 12, 2019

Record Details

An FDA pre-approval inspection of Yung Shin Pharmaceutical Co., Ltd. in Tachia, Taiwan, was conducted from September 9-12, 2019. This inspection, carried out under the regulatory framework of CP 7346.832 for Pre-Approval Inspections, evaluated the manufacturing facility for specific tablet products. The inspection was classified as "Voluntary Action Indicated" (VAI). Main issues observed included deficiencies in laboratory controls, specifically the lack of scientifically sound specifications to ensure drug product identity, strength, quality, and purity. Furthermore, drug products were not stored under conditions appropriate to maintain their identity, strength, quality, and purity. Following the inspection, an FDA-483 form detailing these observations was issued to company management. Yung Shin Pharmaceutical committed to providing a formal written response within 15 business days. Although the inspector recommended an "acceptable" status for the firm's manufacturing role, the final decision regarding the acceptability of the inspected tablets will be made by the FDA's Center for Drug Evaluation and Research (CDER).

Company
Yung Shin Pharmaceutical Industry Co., Ltd.
Inspection date
September 12, 2019
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Paul C. Mouris (GDUFA Supervisory Investigator)
  • Kareem Neal (other)
  • Craig W. Swanson (Deputy District Director)
  • Samina S. Khan
View Company Profile

ID · a44aaf11-ddd8-440b-a9aa-dac91953547c

Other documents for Yung Shin Pharmaceutical Industry Co., Ltd.
  • EIR - 2021-06-21June 21, 2021
  • 483 - 2019-10-22October 22, 2019
  • EIR - 2019-10-22October 22, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Yung Shin Pharmaceutical Industry Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.